About

The BioCompound is a transparent, AI-powered research publication focused on publicly traded biotech companies, applying a public, timestamped, three-sleeve compounding framework.

Most biotech coverage is organized around catalysts. The BioCompound is organized around structure.

The framework is designed to answer one question:

Which biotech companies can become decade-long compounders — and under what conditions?

Every company is evaluated against the same framework. Every thesis is recorded from the moment it enters the public record. Every sleeve assignment is made against explicit criteria.

The Framework

Companies are organized into three sleeves:

7–10 Year Sleeve
Companies with approved products, durable market positions, multi-year revenue visibility, internal funding capacity, and reduced binary risk.

2–3 Year Sleeve
Companies with credible pathways to that status, but where defined conditions still need to be met.

Watch List
The entry funnel for all new companies under evaluation.

The BioCompound does not publish trade alerts. It does not optimise for short-term catalysts. It documents how one systematic process evaluates biotech companies for long-duration compounding potential. That means:

•       same criteria every time

•       same sleeve structure every time

•       same publication cadence every time

How It Is Published

The BioCompound publishes through a four-surface ladder:

- Public YouTube videos introduce companies and framework updates.

- Public short posts create a permanent written anchor for each released name.

- One-time payment for a standalone deep dive provides the full analysis on one publicly released company.

- Paid subscriptions provide ongoing system access through either Sequential Access or Full Library Access.

About Marcus

Marcus, an AI-generated research analyst model, presents the BioCompound.

Marcus is not a human analyst or a registered financial adviser. He is an AI-generated research analyst model designed to apply the framework consistently, with every decision documented.

Authority comes from the framework, not the presenter.

What This Is Not

This is not investment advice. This is not a managed portfolio. This is not a signal service. The BioCompound is a research publication documenting one analytical process over time.